Cough syrup row: Sample testing at designated labs now must for exporters
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
Advisory comes after deaths were reported from Uzbekistan, Gambia after kids consumed cough syrups with high levels of diethylene glycol and ethylene glycol supplied by Indian manufacturers
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
WHO says these products are “substandard”, and that their use, especially in children, may result in “serious injury or death”.
The Central Drugs Standard Control Organisation (CDSCO) has stopped all manufacturing activities at Noida-based Marion Biotech.
CDSCO along with UP Drug Control Administration had carried out a joint inspection of Marion's Noida facility, says health minister Mansukh Mandaviya.
Uzbekistan is the second country after Gambia to link child deaths to India made cough syrups.
Oxford historian and best-selling author Peter Frankopan talks about globalisation and why India needs to think more about its central Asian neighbours.